CN1231237C - Medicine for treating hyperosteogeny - Google Patents
Medicine for treating hyperosteogeny Download PDFInfo
- Publication number
- CN1231237C CN1231237C CN 02113361 CN02113361A CN1231237C CN 1231237 C CN1231237 C CN 1231237C CN 02113361 CN02113361 CN 02113361 CN 02113361 A CN02113361 A CN 02113361A CN 1231237 C CN1231237 C CN 1231237C
- Authority
- CN
- China
- Prior art keywords
- radix
- root
- wine
- medicine
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides a medicine for treating hyperosteogeny, which takes eucommia bark, rehmannia root, matrimony vine, cibot rhizome, Chinese magnolivine fruit, cassia twig, angelica, fleeceflower root, hairy antler, immature orange fruit, Chinese taxillus herb, white ginseng, siebold wildginger herb, prepared rhizome of rehmannia, safflower, common clubmoss herb, doubleteeth pubesscent angelica root, notopterygium root, magnolia bark, divaricate saposhnikovia root, ledebouriella root, tuckahoe, dahurian angelica, etc. as raw materials, and medicinal liquor is obtained by the way that the raw materials are soked in liquor. The present invention has the advantages of unique formula, obvious and quick therapeutic effect, and no toxic or side effect. The present invention provides a pure Chinese medicinal preparation with the functions for nourishing blood, benefiting qi, promoting blood circulation, removing obstruction in the collateral, dissipating blood stasis, and eliminating wind and dampness for treating hypersteogeny.
Description
The present invention relates to a kind of medicine, especially a kind of oral medicine that is used for the treatment of hyperosteogeny.
Osteoarthritis is a kind of comparatively common disease that is difficult to effect a radical cure, and often is accompanied by the growth at age, forms multiple disease.This disease is also because of the birth defect in joint, and many reasons such as joint deformity cause due to the non-inflammation degeneration and edge, joint hyperosteogeny of articular cartilage.It is divided into two kinds of constitutional and Secondary cases.Constitutional is meant the increase of following the age and the disease that causes, and is irrelevant with other diseases.Secondary cases then is that can get involved simultaneously in several joints by caused diseases of pathological changes such as damage, inflammation, heredity and metabolism, endocrine.The women is often even more serious than the male among the patient, and the disease that causes because of joint inflammation such as the hip of cervical vertebra, thoracic vertebra, lumbar vertebra and the lower limb of many tired and spinal column, knee joint, ankles especially is in the directly influence, the active key factor of old people.For many years, this pertinacious disease is perplexing numerous patients always, and not only the medical expense height is difficult to cure, but also brings the inconvenience of great misery and action to the patient.Still do not have at present development sick here in the specific drugs energy, the medicine of great majority treatment hyperosteogeny only plays the effect of mitigate the disease.Therefore, be necessary prior art is improved.
The object of the present invention is to provide a kind ofly to have blood yiqi, promoting blood circulation to remove obstruction in the collateral, dissipating blood stasis blood, evil-wind expelling and dampness removing, and the pure Chinese medicinal preparation of instant effect, cure rate height, the treatment hyperosteogeny that has no side effect.
The medicine of treatment hyperosteogeny of the present invention is made up of the raw material of following weight portion:
Cortex Eucommiae 50-100 part, Radix Rehmanniae 50-100 part is given birth to Radix Paeoniae Alba 30-50 part,
Fructus Lycii 50-100 part, Rhizoma Cibotii 50-80 part, Fructus Schisandrae Chinensis 50-100 part,
Ramulus Cinnamomi 30-100 part, Radix Angelicae Sinensis 100-150 part, Radix Polygoni Multiflori 50-150 part,
Cornu Cervi Pantotrichum 50-100 part, Fructus Aurantii Immaturus 30-50 part, Herba Taxilli 50-100 part,
Radix Ginseng 30-50 part, Herba Asari 50-60 part, Fructus Psoraleae 50-100 part,
Radix Rehmanniae Preparata 100-150 part, Flos Carthami 30-100 part, Herba Lycopodii 50-100 part,
Radix Angelicae Pubescentis 50-100 part, Rhizoma Et Radix Notopterygii 50-100 part, Cortex Magnoliae Officinalis 50-100 part,
Radix Saposhnikoviae 30-50 part, Poria 50-100 part, Rhizoma Chuanxiong 50-100 part,
Radix Angelicae Dahuricae 50-100 part, Radix Et Rhizoma Rhei 20-50 part, Lignum Dalbergiae Odoriferae 50-150 part.
The present invention is in conjunction with China's Chinese medicine theory, and the treatment of bone, muscle is adopted to control the kidney treating the liver, and controlling spleen, to control lung be auxilliary, takes into account invigorating qi and benefiting blood, promoting blood circulation to remove obstruction in the collateral, and assistant is with the principle of evil-wind expelling and dampness removing, and is logical
Cross and improve the microcirculation that focus is vertebral body, soft tissue, cartilage sclerotin, play the effect that takes stopgap measures and effect a permanent cure.Medicine provided by the invention also has dissipating blood stasis blood, promoting blood circulation, the microcirculatory effect of promotion, and taking convenience, instant effect, cure rate height,, side effect nontoxic to human body.
Preparation method of the present invention is: after above-mentioned each component raw material is concocted arrangement with prior art, added edible steeping in wine bubble 6-8 month, the capacity for liquor that adds is: raw material: wine=1: 5-6, the concentration of wine is good with 51-54 degree wine, removes slag to get the medicated wine that liquid promptly gets the present invention.
Be the medicine that shows the present invention effect to the treatment hyperosteogeny, the present invention selects not patient's 126 examples of l department sex, all ages and classes, different medical histories to carry out clinical observation, male patient's 86 examples wherein, female patient 40 examples, 30-40 year patient's 12 examples, 41-50 year patient's 58 examples, 51-60 year patient's 46 examples, patient's 10 examples more than 60 years old, the elder of medical history 30 years, the shortest person 3 months.Clinical symptoms shows as: lumbago and skelalgia, and pain in the shoulder and back, numb limbs and tense tendons, movable function obstacle are carrying out property to be increased the weight of.Diagnose lumbar vertebra hyperosteogeny 51 examples wherein, thoracic dorsal vertebrae hyperosteogeny 18 examples, breast lumbar vertebra hyperosteogeny 14 examples, hyperosteogeny of cervical vertebra 23 examples, outmoded compression fracture 20 examples of lumbar vertebra according to X-ray sheet and the described symptom of patient.Therapeutic Method: oral 2 times of every day, each 20-60 milliliter, 10 days is a course of treatment.Light disease person takes effect a course of treatment; Moderate disease person takes effect three courses of treatment: serious symptom person takes effect six courses of treatment, the no rebound phenomenon of recovering.Patient evident in efficacy, its transference cure, activity freely, the labour force recovers, and does not have any clinical symptoms recurrence; The patient that curative effect is general, its symptom obviously alleviates, and pain time shortens, and prolong at interval: invalid patient, its clinical symptoms is not extenuated.Therapeutic effect: effect shows author 79 people, and does not have a people to recur again, effect general person 45 people, nonresponder 2 people.
Bone matrix hyperplasia is a kind of comparatively common stubborn disease.Its main pathology is degenerated for the cartilage degeneration, the compensatory reparation of body makes subchondral bone matter hypertrophy, and form bone at the B﹠J edge perverse, but the bony spur of body and the thickening pressuring nerve of ligament and cause local symptom and radioactivity symptom, position difference, symptom are also inequality.At cervical part of esophagus arm nerve compression, easily produce shoulder and back ache, numbness of the fingers etc.; Duan Yi causes intercostal neuralgia at breast, even the outbreak of similar angina pectoris sample etc.; Cause easily that at waist the lower limb pain fiber crops are bloated, cause difficulty in walking etc., in a word, for many years, this pertinacious disease is perplexing countless patients always, treats with the present invention's medicine and has obtained significant curative effect.
Embodiment 1
Take by weighing raw material (gram) by following proportioning:
The Cortex Eucommiae 50, the Radix Rehmanniae 100 is given birth to Radix Paeoniae Alba 30,
Fructus Lycii 50, Rhizoma Cibotii 50, Fructus Schisandrae Chinensis 100,
Ramulus Cinnamomi 100, Radix Angelicae Sinensis 100, Radix Polygoni Multiflori 50,
Cornu Cervi Pantotrichum 50, Fructus Aurantii Immaturus 50, Herba Taxilli 100,
Radix Ginseng 30, Herba Asari 50, Fructus Psoraleae 50,
Radix Rehmanniae Preparata 100, Flos Carthami 30, Herba Lycopodii 50,
Radix Angelicae Pubescentis 50, Rhizoma Et Radix Notopterygii 100, Cortex Magnoliae Officinalis 100,
Radix Saposhnikoviae 30, Poria 50, Rhizoma Chuanxiong 50,
The Radix Angelicae Dahuricae 100, Radix Et Rhizoma Rhei 20, Lignum Dalbergiae Odoriferae 50.
Production method is as follows:
After above-mentioned each component raw material concocted arrangement with prior art, added edible steeping in wine bubble 6-8 month, the capacity for liquor of adding is: raw material: wine=1: 5-6, the concentration of wine is good with S 1-54 degree wine, removes slag and gets the medicated wine that liquid promptly gets the present invention.
Embodiment 2
Take by weighing raw material (gram) by following proportioning, and produce medicated wine with the method for embodiment 1:
The Cortex Eucommiae 100, the Radix Rehmanniae 50 is given birth to Radix Paeoniae Alba 50,
Fructus Lycii 100, Rhizoma Cibotii 80, Fructus Schisandrae Chinensis 50,
Ramulus Cinnamomi 30, Radix Angelicae Sinensis 150, Radix Polygoni Multiflori 150,
Cornu Cervi Pantotrichum 100, Fructus Aurantii Immaturus 30, Herba Taxilli 50,
Radix Ginseng 50, Herba Asari 60, Fructus Psoraleae 100,
Radix Rehmanniae Preparata 150, Flos Carthami 100, Herba Lycopodii 100,
Radix Angelicae Pubescentis 100, Rhizoma Et Radix Notopterygii 50, Cortex Magnoliae Officinalis 50,
Radix Saposhnikoviae 50, Poria 100, Rhizoma Chuanxiong 100,
The Radix Angelicae Dahuricae 50, Radix Et Rhizoma Rhei 50, Lignum Dalbergiae Odoriferae 150.
Embodiment 2
Take by weighing raw material (gram) by following proportioning, and produce medicated wine with the method for embodiment 1:
The Cortex Eucommiae 70, the Radix Rehmanniae 70 is given birth to Radix Paeoniae Alba 40,
Fructus Lycii 80, Rhizoma Cibotii 60, the five tastes 70,
Ramulus Cinnamomi 50, Radix Angelicae Sinensis 120, Radix Polygoni Multiflori 100,
Cornu Cervi Pantotrichum 60, Fructus Aurantii Immaturus 40, Herba Taxilli 80,
Radix Ginseng 40, Herba Asari 55, Fructus Psoraleae 70,
Radix Rehmanniae Preparata 110, Flos Carthami 50, Herba Lycopodii 80,
Radix Angelicae Pubescentis 70, Rhizoma Et Radix Notopterygii 80, Cortex Magnoliae Officinalis 70,
Radix Saposhnikoviae 40, Poria 70, Rhizoma Chuanxiong 80,
The Radix Angelicae Dahuricae 70, Radix Et Rhizoma Rhei 30, Lignum Dalbergiae Odoriferae 100.
Claims (4)
1, a kind of medicine for the treatment of hyperosteogeny is characterized in that it is the medicament of being made by following materials of weight proportions:
Cortex Eucommiae 50-100 part, Radix Rehmanniae 50-100 part is given birth to Radix Paeoniae Alba 30-50 part,
Fructus Lycii 50-100 part, Rhizoma Cibotii 50-80 part, Fructus Schisandrae Chinensis 50-100 part,
Ramulus Cinnamomi 30-100 part, Radix Angelicae Sinensis 100-150 part, Radix Polygoni Multiflori 50-150 part,
Cornu Cervi Pantotrichum 50-100 part, Fructus Aurantii Immaturus 30-50 part, Herba Taxilli 50-100 part,
Radix Ginseng 30-50 part, Herba Asari 50-60 part, broken event 50-100 part,
Radix Rehmanniae Preparata 100-150 part, Flos Carthami 30-100 part, Herba Lycopodii 50-100 part,
Radix Angelicae Pubescentis 50-100 part, Rhizoma Et Radix Notopterygii 50-100 part, Cortex Magnoliae Officinalis 50-100 part,
Radix Saposhnikoviae 30-50 part, Poria 50-100 part, Rhizoma Chuanxiong 50-100 part,
Radix Angelicae Dahuricae 50-100 part, Radix Et Rhizoma Rhei 20-50 part, Lignum Dalbergiae Odoriferae 50-150 part.
2, medicine according to claim 1 is characterized in that said medicament is the preparation of the edible wine extraction of a kind of usefulness.
3, medicine according to claim 1, the preparation method that it is characterized in that described medicine is: after above-mentioned each component raw material is concocted arrangement with prior art, added edible steeping in wine bubble 6-8 month, the capacity for liquor of adding is: raw material: wine=1: 5-6, remove slag and get the medicated wine that liquid promptly gets the present invention.
4, medicine according to claim 3, the concentration that it is characterized in that wine is the 51-54 degree.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02113361 CN1231237C (en) | 2002-02-08 | 2002-02-08 | Medicine for treating hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02113361 CN1231237C (en) | 2002-02-08 | 2002-02-08 | Medicine for treating hyperosteogeny |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1436559A CN1436559A (en) | 2003-08-20 |
| CN1231237C true CN1231237C (en) | 2005-12-14 |
Family
ID=27628424
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02113361 Expired - Fee Related CN1231237C (en) | 2002-02-08 | 2002-02-08 | Medicine for treating hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1231237C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100411649C (en) * | 2005-12-22 | 2008-08-20 | 清华大学深圳研究生院 | Traditional Chinese medicine for treating rheumatic and rheumatoid arthritis |
| CN104415110A (en) * | 2013-09-09 | 2015-03-18 | 廖国建 | Medicinal liquor for treating hyperostosis |
-
2002
- 2002-02-08 CN CN 02113361 patent/CN1231237C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1436559A (en) | 2003-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1118285C (en) | Shubi plaster for treating arthralgia due to wind-cold-dampness | |
| CN1907410A (en) | Chinese traditional medicine preparation for treating bone fracture and traumatic injury | |
| CN1257715A (en) | Tincture for treating rheumatoid arthritis and its preparing process | |
| CN101703662B (en) | Oral Chinese medicament for treating hyperosteogeny | |
| CN1733047A (en) | Medicine for treating traumatic injury | |
| CN1135909A (en) | Medicine for hyperosteogeny and wind-cold syndrome | |
| CN1231237C (en) | Medicine for treating hyperosteogeny | |
| CN1843421A (en) | Rheumatoid disease treating medicine | |
| CN1319577C (en) | Medicine for treating cervical disease and its preparation | |
| CN1324650A (en) | Effective medicine for treating cervical vertebra disease as one kind of intractable disease | |
| CN101496838A (en) | Chinese medicament preparation for treating hyperosteogeny and rheumatism and preparation method thereof | |
| CN107551229A (en) | A kind of pharmaceutical composition and its production and use | |
| CN1051471C (en) | Drug composition for curing osteoporosis | |
| CN1663577A (en) | Chinese medicinal composition for treating rheumatic and rheumatoid arthritis | |
| CN1970067B (en) | Chinese medicinal formulation for treating vertebrae hyperosteogeny, protrusion of intervertebral disc and spinal stenosis | |
| CN1238021C (en) | Medicine for treating osteoproliferation | |
| CN1256127C (en) | Chinese patent medicine for injury of muscle and joint and its preparation | |
| CN101181557B (en) | Chinese medicine composition for curing ankylosing spondylitis, rheumatism and rheumatoid as well as method of making the same | |
| CN1850238A (en) | Medicine composition for treating backbone and joint disease | |
| CN1255155C (en) | Medicine for curing rheumatic and rheumatoid diseases and its preparing method | |
| CN109432309A (en) | Chinese medicine composition, exterior-applied medical wine and its preparation method and application | |
| CN1095369C (en) | Hantongling capsule for treatment of wind-cold and wind-dampness syndrome | |
| CN1290551C (en) | A Chinese medicinal composition for invigorating kidney and strengthening bone | |
| CN101584846A (en) | Traditional Chinese medicine for treating cervical spondylosis | |
| CN1188152C (en) | Composite Chinese medicine for treating protrusion of lumber interverterbral disc |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20051214 Termination date: 20130208 |